InvestorsHub Logo
Followers 3
Posts 235
Boards Moderated 0
Alias Born 08/22/2016

Re: None

Monday, 02/05/2018 10:36:37 AM

Monday, February 05, 2018 10:36:37 AM

Post# of 2221
Brokerage firms currently have a positive stance on shares of Akers Biosciences, Inc. (NASDAQ:AKER). The majority of analysts covering the equity have either a Buy or Strong Buy recommendation on the stock, yielding a consensus score of 2.00. Those same analysts are projecting that the stock will reach $4.00 on a short term basis.

http://alphabetastock.com/2018/02/05/hot-stocks-alert-akers-biosciences-inc-nasdaq-aker-2/